Asset 1

Digital health

Our tech and life sciences teams provide seamless expert advice for global companies and investors in the fast-growing digital health industry. Our clients are renowned investors, from prominent early-stage funds to the largest global venture capital firms, and ambitious global digital health companies who, with our support, are revolutionizing the industry.

Through our established investor network we create transformative funding solutions for clients at all business stages, creating substantial financial foundations for growth and on-going development.

With experts in the UK, Europe, the Middle East, and Asia, together with our key partner collaborations in the US, our specialist approach in the provision of finance and capital raising, regulatory and data privacy, and IP, coupled with cross border expertise, provides the foundations for significant and sustainable global expansion for our clients. Our comprehensive awareness of the regulatory challenges facing emerging digital health companies both internally, and among ecosystem partners, is invaluable.

Supported by our data privacy and security teams, we successfully resolve personal data issues particular to digital and app-based devices and the broader regulatory challenges faced by our clients within a rapidly changing industry.

Similarly, our highly regarded IP team helps digital health companies achieve important milestones by securing, developing, and protecting valuable IP assets. This includes restructuring and executing sophisticated agreements and collaborations, partnerships and licensing agreements, and acquiring and divesting valuable businesses through strategic M&A.

stethoscope
Life sciences & healthcare

Targeted treatments – Part 4: patenting digital devices

16 October 2020
Briefing

by Paul England, DPhil

Click here to find out more
paper plane
Disputes & investigations

Goodbye CE, hello UKCA

18 September 2020
QUICK READ

by multiple authors

Click here to find out more
robotic-arm
Life sciences & healthcare

Alison Dennis discusses the new framework for regulating medical devices and IVDs

3 September 2020

by Alison Dennis

Click here to find out more
DNA helix
Life sciences & healthcare

Justyna Ostrowska discusses the impact of new MHRA Apps Guidance on the digital health industry

18 August 2020

by Justyna Ostrowska

Click here to find out more

Related events

There are no upcoming events